Dose Escalation by Boosting Radiation Dose Within the Primary Tumor Using FDG-PET-CT Scan in Stage IB, II and III NSCLC (PET Boost)

Clinical Trial ID NCT01024829

Rank	Title	Journal	Year	PubWeight™‹?›
1	PET-CT for radiotherapy treatment planning and response monitoring in solid tumors.	Nat Rev Clin Oncol	2011	1.11
2	Functional MRI for radiotherapy dose painting.	Magn Reson Imaging	2012	0.92
3	Novel approaches of chemoradiotherapy in unresectable stage IIIA and stage IIIB non-small cell lung cancer.	Oncologist	2012	0.91
4	Radiation dose effect in locally advanced non-small cell lung cancer.	J Thorac Dis	2014	0.87
5	PET in the management of locally advanced and metastatic NSCLC.	Nat Rev Clin Oncol	2015	0.84
6	Multiparametric imaging of patient and tumour heterogeneity in non-small-cell lung cancer: quantification of tumour hypoxia, metabolism and perfusion.	Eur J Nucl Med Mol Imaging	2015	0.84
7	Characterization of tumor heterogeneity using dynamic contrast enhanced CT and FDG-PET in non-small cell lung cancer.	Radiother Oncol	2013	0.81
8	A critical review of recent developments in radiotherapy for non-small cell lung cancer.	Radiat Oncol	2016	0.80
9	Positron emission tomography to assess hypoxia and perfusion in lung cancer.	World J Clin Oncol	2014	0.79
10	Validation of functional imaging as a biomarker for radiation treatment response.	Br J Radiol	2015	0.75